Antiviral Drugs Used to Treat COVID-19 are not Liver Safe: A Comparative Experimental Study
Objective: This study aimed to determine whether the medication alone might be effective in the drug-induced liver damage that was reported during coronavirus disease-2019 (COVID-19) in healthy rats. Methods: Thirty-three 8-10 week old Wistar albino male rats were separated into seven groups: the s...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Galenos Publishing House
2024-07-01
|
| Series: | Gazi Medical Journal |
| Subjects: | |
| Online Access: | https://gazimedj.com/articles/antiviral-drugs-used-to-treat-covid-19-are-not-liver-safe-a-comparative-experimental-study/doi/gmj.2024.4030 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841525829875531776 |
|---|---|
| author | Asiye Aslı Emniyet Sert Cemile Merve Seymen Gülnur Take Kaplanoğlu |
| author_facet | Asiye Aslı Emniyet Sert Cemile Merve Seymen Gülnur Take Kaplanoğlu |
| author_sort | Asiye Aslı Emniyet Sert |
| collection | DOAJ |
| description | Objective: This study aimed to determine whether the medication alone might be effective in the drug-induced liver damage that was reported during coronavirus disease-2019 (COVID-19) in healthy rats.
Methods: Thirty-three 8-10 week old Wistar albino male rats were separated into seven groups: the sham control groups for intravenous, subcutaneous, and gavage stress; the acyclovir, hydroxychloroquine, anakinra, and favipiravir groups. At the end of the experimental period, hematoxylin-eosin and silver impregnation histochemical, tumour necrosis factor-alpha (TNF-α)/interleukin-1 beta (IL-1β)/IL-6 immunohistochemical stainings were performed on liver tissue. Data were supported statistically.
Results: Morphological degeneration were observed in both the classic liver lobule and portal triad regions with drug administration. The intensity of the reticular fibers was found to be decreasing in the medicament groups, especially around the vena centralis. TNF-α, IL-1β, and IL-6 immunoreactivities were found to be significantly higher in the antiviral drug-administered groups than in the sham control groups.
Conclusion: It is concluded that liver damage was reported for treating COVID-19 triggered by the medicines applied. |
| format | Article |
| id | doaj-art-14f47c391f37438f91b53bc8f736145f |
| institution | Kabale University |
| issn | 2147-2092 |
| language | English |
| publishDate | 2024-07-01 |
| publisher | Galenos Publishing House |
| record_format | Article |
| series | Gazi Medical Journal |
| spelling | doaj-art-14f47c391f37438f91b53bc8f736145f2025-01-17T06:27:33ZengGalenos Publishing HouseGazi Medical Journal2147-20922024-07-0135331532410.12996/gmj.2024.4030Antiviral Drugs Used to Treat COVID-19 are not Liver Safe: A Comparative Experimental StudyAsiye Aslı Emniyet Sert0https://orcid.org/0000-0001-5980-8694Cemile Merve Seymen1https://orcid.org/0000-0002-3661-3488Gülnur Take Kaplanoğlu2https://orcid.org/0000-0002-3661-3488Department of Histology and Embryology Gazi University Faculty of Medicine, Ankara, TürkiyeDepartment of Histology and Embryology Gazi University Faculty of Medicine, Ankara, TürkiyeDepartment of Histology and Embryology Gazi University Faculty of Medicine, Ankara, TürkiyeObjective: This study aimed to determine whether the medication alone might be effective in the drug-induced liver damage that was reported during coronavirus disease-2019 (COVID-19) in healthy rats. Methods: Thirty-three 8-10 week old Wistar albino male rats were separated into seven groups: the sham control groups for intravenous, subcutaneous, and gavage stress; the acyclovir, hydroxychloroquine, anakinra, and favipiravir groups. At the end of the experimental period, hematoxylin-eosin and silver impregnation histochemical, tumour necrosis factor-alpha (TNF-α)/interleukin-1 beta (IL-1β)/IL-6 immunohistochemical stainings were performed on liver tissue. Data were supported statistically. Results: Morphological degeneration were observed in both the classic liver lobule and portal triad regions with drug administration. The intensity of the reticular fibers was found to be decreasing in the medicament groups, especially around the vena centralis. TNF-α, IL-1β, and IL-6 immunoreactivities were found to be significantly higher in the antiviral drug-administered groups than in the sham control groups. Conclusion: It is concluded that liver damage was reported for treating COVID-19 triggered by the medicines applied.https://gazimedj.com/articles/antiviral-drugs-used-to-treat-covid-19-are-not-liver-safe-a-comparative-experimental-study/doi/gmj.2024.4030antiviral agentscoronaviruslivertnf-αil-1βil-6 |
| spellingShingle | Asiye Aslı Emniyet Sert Cemile Merve Seymen Gülnur Take Kaplanoğlu Antiviral Drugs Used to Treat COVID-19 are not Liver Safe: A Comparative Experimental Study Gazi Medical Journal antiviral agents coronavirus liver tnf-α il-1β il-6 |
| title | Antiviral Drugs Used to Treat COVID-19 are not Liver Safe: A Comparative Experimental Study |
| title_full | Antiviral Drugs Used to Treat COVID-19 are not Liver Safe: A Comparative Experimental Study |
| title_fullStr | Antiviral Drugs Used to Treat COVID-19 are not Liver Safe: A Comparative Experimental Study |
| title_full_unstemmed | Antiviral Drugs Used to Treat COVID-19 are not Liver Safe: A Comparative Experimental Study |
| title_short | Antiviral Drugs Used to Treat COVID-19 are not Liver Safe: A Comparative Experimental Study |
| title_sort | antiviral drugs used to treat covid 19 are not liver safe a comparative experimental study |
| topic | antiviral agents coronavirus liver tnf-α il-1β il-6 |
| url | https://gazimedj.com/articles/antiviral-drugs-used-to-treat-covid-19-are-not-liver-safe-a-comparative-experimental-study/doi/gmj.2024.4030 |
| work_keys_str_mv | AT asiyeaslıemniyetsert antiviraldrugsusedtotreatcovid19arenotliversafeacomparativeexperimentalstudy AT cemilemerveseymen antiviraldrugsusedtotreatcovid19arenotliversafeacomparativeexperimentalstudy AT gulnurtakekaplanoglu antiviraldrugsusedtotreatcovid19arenotliversafeacomparativeexperimentalstudy |